Works matching IS 2574173X AND DT 2022 AND VI 42 AND IP 2

Results: 20

COVID‐19 vaccination did not improve employee mental health: A prospective study in an early phase of vaccination in Japan.
Published in:
Neuropsychopharmacology Reports, 2022, v. 42, n. 2, p. 230, doi. 10.1002/npr2.12250
By:
- Sasaki, Natsu;
- Kuroda, Reiko;
- Tsuno, Kanami;
- Imamura, Kotaro;
- Kawakami, Norito
Publication type:
Article
Role of noradrenergic transmission within the ventral bed nucleus of the stria terminalis in nicotine withdrawal‐induced aversive behavior.
Published in:
Neuropsychopharmacology Reports, 2022, v. 42, n. 2, p. 233, doi. 10.1002/npr2.12252
By:
- Arakaki, Saya;
- Minami, Masabumi
Publication type:
Article
Relationship between autistic traits and social functioning in healthy individuals.
Published in:
Neuropsychopharmacology Reports, 2022, v. 42, n. 2, p. 226, doi. 10.1002/npr2.12249
By:
- Demizu, Yuria;
- Matsumoto, Junya;
- Yasuda, Yuka;
- Ito, Satsuki;
- Miura, Kenichiro;
- Yamamori, Hidenaga;
- Fujimoto, Michiko;
- Hasegawa, Naomi;
- Ishimaru, Keiichiro;
- Hashimoto, Ryota
Publication type:
Article
A 12‐session relapse prevention program vs psychoeducation in the treatment of Japanese alcoholic patients: A randomized controlled trial.
Published in:
Neuropsychopharmacology Reports, 2022, v. 42, n. 2, p. 205, doi. 10.1002/npr2.12248
By:
- Harada, Takayuki;
- Aikawa, Yuzo;
- Takahama, Mihoko;
- Yumoto, Yosuke;
- Umeno, Mitsuru;
- Hasegawa, Yukako;
- Ohsawa, Shigeo;
- Asukai, Nozomu
Publication type:
Article
Clinical characteristics and treatment outcomes of patients with newly diagnosed schizophrenia: A 4‐year single‐center experience in Saudi Arabia.
Published in:
Neuropsychopharmacology Reports, 2022, v. 42, n. 2, p. 199, doi. 10.1002/npr2.12247
Publication type:
Article
Development of attentional networks during childhood and adolescence: A functional MRI study.
Published in:
Neuropsychopharmacology Reports, 2022, v. 42, n. 2, p. 191, doi. 10.1002/npr2.12246
By:
- Saito, Daisuke N.;
- Fujisawa, Takashi X.;
- Yanaka, Hisakazu T.;
- Fujii, Takeshi;
- Kochiyama, Takanori;
- Makita, Kai;
- Tomoda, Akemi;
- Okazawa, Hidehiko
Publication type:
Article
Subjective assessment of participants in education programs on clinical practice guidelines in the field of psychiatry.
Published in:
Neuropsychopharmacology Reports, 2022, v. 42, n. 2, p. 221, doi. 10.1002/npr2.12245
By:
- Ogasawara, Kazuyoshi;
- Numata, Shusuke;
- Hasegawa, Naomi;
- Nakataki, Masahito;
- Makinodan, Manabu;
- Ohi, Kazutaka;
- Takeshima, Masahiro;
- Tsuboi, Takashi;
- Hashimoto, Naoki;
- Onitsuka, Toshiaki;
- Muraoka, Hiroyuki;
- Hori, Hikaru;
- Ichihashi, Kayo;
- Inagaki, Takahiko;
- Yasui‐Furukori, Norio;
- Hishimoto, Akitoyo;
- Sugiyama, Nobuhiro;
- Fukumoto, Kentaro;
- Nagasawa, Tatsuya;
- Matsumoto, Junya
Publication type:
Article
Efficacy of clozapine for long‐stay patients with treatment‐resistant schizophrenia: 4‐year observational study.
Published in:
Neuropsychopharmacology Reports, 2022, v. 42, n. 2, p. 183, doi. 10.1002/npr2.12244
By:
- Mizuno, Kentaro;
- Mizuno, Emiko;
- Suekane, Akira;
- Shiratsuchi, Toshiaki
Publication type:
Article
Retention and impairment of neurocognitive functions in mild cognitive impairment and Alzheimer's disease with a comprehensive neuropsychological test.
Published in:
Neuropsychopharmacology Reports, 2022, v. 42, n. 2, p. 174, doi. 10.1002/npr2.12243
By:
- Yao, Lu;
- Aoyama, Shinsuke;
- Ouchi, Atushi;
- Yamamoto, Yasuji;
- Sora, Ichiro
Publication type:
Article
Association between psychotropic prescriptions and the total amount of psychotropics ingested during an intentional overdose: A single‐center retrospective study.
Published in:
Neuropsychopharmacology Reports, 2022, v. 42, n. 2, p. 166, doi. 10.1002/npr2.12242
By:
- Tanahashi, Iori;
- Shiganami, Takafumi;
- Iwayama, Takayuki;
- Wake, Taisei;
- Kobayashi, Sayaka;
- Yoshimasu, Haruo
Publication type:
Article
Effectiveness of progressive muscle relaxation technique on anxiety caused by Covid‐19 in pregnant women: A randomized clinical trial.
Published in:
Neuropsychopharmacology Reports, 2022, v. 42, n. 2, p. 158, doi. 10.1002/npr2.12241
By:
- Zendehdel, Mojgan;
- Elyasi, Forouzan;
- Jahanfar, Shayesteh;
- Emami‐Sahebi, Azam
Publication type:
Article
Aripiprazole LAI two‐injection start in a 16 year‐old adolescent with schizophrenia.
Published in:
Neuropsychopharmacology Reports, 2022, v. 42, n. 2, p. 241, doi. 10.1002/npr2.12240
By:
- Salvi, Virginio;
- Appignanesi, Cristina;
- Marpepa, Brodinela;
- Orsolini, Laura;
- Volpe, Umberto
Publication type:
Article
Multisectoral actions of mental health during the COVID‐19 pandemic in Mazandaran province of Iran.
Published in:
Neuropsychopharmacology Reports, 2022, v. 42, n. 2, p. 148, doi. 10.1002/npr2.12239
By:
- Ahmadi Livani, Abdolkarim;
- Gohardehi, Farzad;
- Azizi, Marzieh;
- Hashemvarzi, Mahmoud Reza;
- Taghavi, Somayeh;
- Tonekaboni, Sara;
- Golchobi, Ramzanali;
- Zarghami, Mehran;
- Aarabi, Mohsen;
- Elyasi, Forouzan
Publication type:
Article
A case report: Clozapine‐induced leukopenia and neutropenia after mRNA COVID‐19 vaccination.
Published in:
2022
By:
- Imai, Tomoyuki;
- Ochiai, Sho;
- Ishimaru, Takehiro;
- Daitoku, Hayato;
- Miyagawa, Yusuke;
- Fukuhara, Ryuji;
- Boku, Shuken;
- Takebayashi, Minoru
Publication type:
Case Study
Psychological stress of emergency medical staff after the largest mass murder incident in post‐World War II era.
Published in:
Neuropsychopharmacology Reports, 2022, v. 42, n. 2, p. 142, doi. 10.1002/npr2.12237
By:
- Arai, Hisatoshi;
- Inoue, Katsuo;
- Takizawa, Takeya;
- Yamaya, Tatsuhiro;
- Asari, Yasushi;
- Miyaoka, Hitoshi
Publication type:
Article
Is SARS‐CoV‐2 seroconversion a risk factor for severe and acute psychiatric symptoms in children?
Published in:
Neuropsychopharmacology Reports, 2022, v. 42, n. 2, p. 218, doi. 10.1002/npr2.12236
By:
- Ayrolles, Anaël;
- Ellul, Pierre;
- Trebossen, Vincent;
- Houhou‐Fidouh, Nadira;
- Bonacorsi, Stephane;
- Descamps, Diane;
- Delorme, Richard
Publication type:
Article
Safety and tolerability of aripiprazole in patients with psychosis associated with Parkinson's disease—Results of a multicenter open trial.
Published in:
Neuropsychopharmacology Reports, 2022, v. 42, n. 2, p. 135, doi. 10.1002/npr2.12235
By:
- Kashihara, Kenichi;
- Maeda, Tetsuya;
- Yoshida, Kazuto
Publication type:
Article
Evaluation of a natural S‐equol supplement in treating premenstrual symptoms and the effect of the gut microbiota: An open‐label pilot study.
Published in:
Neuropsychopharmacology Reports, 2022, v. 42, n. 2, p. 127, doi. 10.1002/npr2.12234
By:
- Takeda, Takashi;
- Chiba, Yasutaka
Publication type:
Article
Alfaxalone improved in acute stress‐induced tactile hypersensitivity and anxiety‐like behavior in mice.
Published in:
Neuropsychopharmacology Reports, 2022, v. 42, n. 2, p. 213, doi. 10.1002/npr2.12233
By:
- Yoshizawa, Kazumi;
- Ukai, Saki;
- Kuroda, Junpei;
- Yamauchi, Tsugumi;
- Yamada, Daisuke;
- Saitoh, Akiyoshi;
- Iriyama, Satoshi;
- Nishino, Shoichi;
- Miyazaki, Satoru
Publication type:
Article
Issue Information.
Published in:
Neuropsychopharmacology Reports, 2022, v. 42, n. 2, p. 125, doi. 10.1002/npr2.12185
Publication type:
Article